{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T18:49:16Z","timestamp":1779907756832,"version":"3.53.1"},"reference-count":34,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2006,8,1]],"date-time":"2006-08-01T00:00:00Z","timestamp":1154390400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Brain Research"],"published-print":{"date-parts":[[2006,8]]},"DOI":"10.1016\/j.brainres.2006.05.076","type":"journal-article","created":{"date-parts":[[2006,7,13]],"date-time":"2006-07-13T12:18:54Z","timestamp":1152793134000},"page":"72-81","source":"Crossref","is-referenced-by-count":21,"title":["The neuroleptic drug, fluphenazine, blocks neuronal voltage-gated sodium channels"],"prefix":"10.1016","volume":"1106","author":[{"given":"Xiaoping","family":"Zhou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Wei","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tony","family":"Priestley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.brainres.2006.05.076_bib1","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/0893-133X(95)00070-T","article-title":"Distribution of fluphenazine and its metabolites in brain regions and other tissues of the rat","volume":"13","author":"Aravagiri","year":"1995","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.brainres.2006.05.076_bib2","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1085\/jgp.50.2.491","article-title":"Time course of TEA(+)-induced anomalous rectification in squid giant axons","volume":"50","author":"Armstrong","year":"1966","journal-title":"J. Gen. Physiol."},{"key":"10.1016\/j.brainres.2006.05.076_bib3","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1001\/jama.1960.03020140024006","article-title":"Postoperative nausea and vomiting. III. Evaluation of the antiemetic drugs fluphenazine (prolixin) and promethazine (phenergan) and comparison with triflupromazine, (vesprin) and cyclizine (marezine)","volume":"172","author":"Bellville","year":"1960","journal-title":"JAMA"},{"key":"10.1016\/j.brainres.2006.05.076_bib4","doi-asserted-by":"crossref","first-page":"1842","DOI":"10.1002\/jps.2600631204","article-title":"Tissue metabolites of trifluoperazine, fluphenazine, prochlorperazine, and perphenazine in the rat: identification and synthesis","volume":"63","author":"Breyer","year":"1974","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.brainres.2006.05.076_bib5","doi-asserted-by":"crossref","first-page":"5301","DOI":"10.1523\/JNEUROSCI.19-13-05301.1999","article-title":"Voltage-dependent neuromodulation of Na+ channels by D1-like dopamine receptors in rat hippocampal neurons","volume":"19","author":"Cantrell","year":"1999","journal-title":"J. Neurosci."},{"key":"10.1016\/j.brainres.2006.05.076_bib6","doi-asserted-by":"crossref","unstructured":"Choi, J.S., Hudmon, A., Waxman, S., Dib-Hajj, S.D., (in press). Calmodulin regulates current density and frequency-dependent inhibition of sodium channel NaV1.8 in DRG neurons. J. Neurophysiol. Epub.","DOI":"10.1152\/jn.00854.2005"},{"key":"10.1016\/j.brainres.2006.05.076_bib7","first-page":"167","article-title":"Fluphenazine: a preliminary study","volume":"20","author":"Darling","year":"1959","journal-title":"Dis. Nerv. Syst."},{"key":"10.1016\/j.brainres.2006.05.076_bib8","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.pnpbp.2003.10.010","article-title":"Double-blind, randomized comparison of olanzapine versus fluphenazine in the long-term treatment of schizophrenia","volume":"28","author":"Dossenbach","year":"2004","journal-title":"Prog. Neuro-psychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.brainres.2006.05.076_bib9","first-page":"263","article-title":"Fluphenazine hydrochloride","volume":"vol. 2","author":"Florey","year":"1973"},{"key":"10.1016\/j.brainres.2006.05.076_bib10","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1097\/00002508-200009000-00002","article-title":"Amitriptyline and fluphenazine in the treatment of postherpetic neuralgia","volume":"16","author":"Graff-Radford","year":"2000","journal-title":"Clin. J. Pain"},{"key":"10.1016\/j.brainres.2006.05.076_bib34","first-page":"404","article-title":"Pharmacological properties of fluphenazine-mustard, an irreversible calmodulin antagonist","volume":"32","author":"Hait","year":"1987","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.brainres.2006.05.076_bib11","doi-asserted-by":"crossref","first-page":"8261","DOI":"10.1523\/JNEUROSCI.23-23-08261.2003","article-title":"Calmodulin binds to the C terminus of sodium channels Nav1.4 and Nav1.6 and differentially modulates their functional properties","volume":"23","author":"Herzog","year":"2003","journal-title":"J. Neurosci."},{"key":"10.1016\/j.brainres.2006.05.076_bib12","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1085\/jgp.69.4.497","article-title":"Local anesthetics: hydrophilic and hydrophobic pathways for the drug\u2013receptor reaction","volume":"69","author":"Hille","year":"1977","journal-title":"J. Gen. Physiol."},{"key":"10.1016\/j.brainres.2006.05.076_bib13","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/S0924-9338(02)00696-X","article-title":"Antiepileptic drugs in schizophrenia: a review","volume":"17","author":"Hosak","year":"2002","journal-title":"Eur. Psychiatry"},{"key":"10.1016\/j.brainres.2006.05.076_bib14","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1021\/js980440c","article-title":"Pharmacokinetics of fluphenazine, a highly lipophilic drug, estimated from a pulse dose of a stable isotopomer in dogs at steady state","volume":"88","author":"Hubbard","year":"1999","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.brainres.2006.05.076_bib15","doi-asserted-by":"crossref","first-page":"2750","DOI":"10.1001\/jama.1990.03440200052020","article-title":"Fluphenazine and postherpetic neuralgia","volume":"263","author":"Hurtig","year":"1990","journal-title":"JAMA"},{"key":"10.1016\/j.brainres.2006.05.076_bib16","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/S0014-2999(02)02074-5","article-title":"A comparison of the receptor binding and HERG channel affinities for a series of antipsychotic drugs","volume":"450","author":"Kongsamut","year":"2002","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.brainres.2006.05.076_bib17","doi-asserted-by":"crossref","first-page":"1810","DOI":"10.1038\/sj.bjp.0701333","article-title":"The effects of neuroleptic and tricyclic compounds on BKCa channel activity in rat isolated cortical neurones","volume":"121","author":"Lee","year":"1997","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.brainres.2006.05.076_bib18","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1097\/00005344-200405000-00014","article-title":"Block of HERG human K(+) channel and IKr of guinea pig cardiomyocytes by chlorpromazine","volume":"43","author":"Lee","year":"2004","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"10.1016\/j.brainres.2006.05.076_bib19","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1001\/archpsyc.1990.01810200069010","article-title":"Fluphenazine dose, clinical response, and extrapyramidal symptoms during acute treatment","volume":"47","author":"Levinson","year":"1990","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.brainres.2006.05.076_bib20","first-page":"479","article-title":"Plasma levels of parent drug and metabolites in patients receiving oral and depot fluphenazine","volume":"25","author":"Marder","year":"1989","journal-title":"Psychopharmacol. Bull."},{"key":"10.1016\/j.brainres.2006.05.076_bib21","doi-asserted-by":"crossref","first-page":"10289","DOI":"10.1523\/JNEUROSCI.2155-04.2004","article-title":"D2 dopamine receptor-mediated modulation of voltage-dependent Na+ channels reduces autonomous activity in striatal cholinergic interneurons","volume":"24","author":"Maurice","year":"2004","journal-title":"J. Neurosci."},{"key":"10.1016\/j.brainres.2006.05.076_bib22","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1111\/j.1471-4159.1986.tb01785.x","article-title":"[3H]Fluphenazine binding to brain membranes: simultaneous measurement of D-1 and D-2 receptor sites","volume":"46","author":"Morgan","year":"1986","journal-title":"J. Neurochem."},{"key":"10.1016\/j.brainres.2006.05.076_bib23","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1111\/j.1476-5381.1989.tb12031.x","article-title":"Block of sodium channels by psychotropic drugs in single guinea-pig cardiac myocytes","volume":"97","author":"Ogata","year":"1989","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.brainres.2006.05.076_bib24","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1113\/jphysiol.1990.sp017906","article-title":"Differential block of sodium and calcium channels by chlorpromazine in mouse neuroblastoma cells","volume":"420","author":"Ogata","year":"1990","journal-title":"J. Physiol. (Lond.)"},{"key":"10.1016\/j.brainres.2006.05.076_bib25","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/S0920-9964(99)00115-2","article-title":"Comparative pharmacology of bipolar disorder and schizophrenia","volume":"39","author":"Post","year":"1999","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.brainres.2006.05.076_bib26","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1523\/JNEUROSCI.22-02-00396.2002","article-title":"Differential inhibition of T-type calcium channels by neuroleptics","volume":"22","author":"Santi","year":"2002","journal-title":"J. Neurosci."},{"key":"10.1016\/j.brainres.2006.05.076_bib27","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/0165-1781(87)90090-4","article-title":"Blood to brain distribution of neuroleptics","volume":"20","author":"Sunderland","year":"1987","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.brainres.2006.05.076_bib28","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1176\/ajp.116.5.457","article-title":"Clinical evaluation of a new phenothiazine tranquilizer, fluphenazine (prolixin)","volume":"116","author":"Taylor","year":"1959","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.brainres.2006.05.076_bib29","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1016\/S0028-3908(01)00007-7","article-title":"Pharmacological characterisation of the human small conductance calcium-activated potassium channel hSK3 reveals sensitivity to tricyclic antidepressants and antipsychotic phenothiazines","volume":"40","author":"Terstappen","year":"2001","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.brainres.2006.05.076_bib30","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1038\/sj.bjp.0705283","article-title":"The antipsychotic drug chlorpromazine inhibits HERG potassium channels","volume":"139","author":"Thomas","year":"2003","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.brainres.2006.05.076_bib31","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1176\/ajp.137.1.80","article-title":"Low neuroleptic serum levels in patients receiving fluphenazine decanoate","volume":"137","author":"Tune","year":"1980","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.brainres.2006.05.076_bib32","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1093\/schbul\/17.2.197","article-title":"Neuroleptic plasma levels","volume":"17","author":"Van Putten","year":"1991","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.brainres.2006.05.076_bib33","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1124\/jpet.103.051086","article-title":"Vinpocetine is a potent blocker of rat NaV1.8 tetrodotoxin-resistant sodium channels","volume":"306","author":"Zhou","year":"2003","journal-title":"J. Pharmacol. Exp. Ther."}],"container-title":["Brain Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006899306015861?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006899306015861?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,4,20]],"date-time":"2019-04-20T00:43:46Z","timestamp":1555721026000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006899306015861"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,8]]},"references-count":34,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2006,8]]}},"alternative-id":["S0006899306015861"],"URL":"https:\/\/doi.org\/10.1016\/j.brainres.2006.05.076","relation":{},"ISSN":["0006-8993"],"issn-type":[{"value":"0006-8993","type":"print"}],"subject":[],"published":{"date-parts":[[2006,8]]}}}